Brief: Theradiag FY Net Profit Grows To 348,000 Euros

Theradiag SA

18/03/2020 17:06

March 18 (Reuters) - Theradiag SA  ALTHE.PA :
    * FY NET PROFIT 348,000 EUR VERSUS -786,000 EUR LOSS YEAR
AGO
    * FY REVENUE EUR 9.63 MILLION VERSUS EUR 8.9 MILLION YEAR
AGO
    * AT DEC 31, 2019, NET CASH STOOD AT EUR 2.9 MILLION,
COMPARED TO
EUR 3.4 MILLION AT DEC 31, 2018
    * EXPOSURE TO COVID-19: BUSINESS CONTINUITY PLAN DEFINED AND
IMPLEMENTED
    * FY OPERATING LOSS EUR 0.6 MILLION VERSUS LOSS EUR 0.7
MILLION
YEAR AGO
    * ON CORONAVIRUS: CONTINUES TO FOLLOW DEVELOPMENTS WITH
UTMOST
ATTENTION AND ADAPT ITS OPERATIONS IN LINE WITH GOVERNMENT
RECOMMENDATIONS
    * ON CORONAVIRUS: A BUSINESS CONTINUITY PLAN HAS BEEN
ESTABLISHED
AND APPLIED FROM MARCH 17, 2020
    * ON CORONAVIRUS: HAS ORGANIZED ITS OPERATIONS IN ORDER TO
GUARANTEE A VOLUME OF PRODUCTION FOR KEY PRODUCTS, ORDER
PROCESSING, SHIPMENTS AND CUSTOMER HOTLINE SERVICE
    * 2019 NET LOSS EXCLUDING NON-RECURRING ITEMS CAME TO €326K,
VIRTUALLY HALVING THE LOSS GENERATED IN 2018
    * ON CORONAVIRUS: HAS IMPLEMENTED ALL REQUIRED MEASURES FOR
ITS
EMPLOYEES, INCLUDING TELEWORKING FOR THOSE ABLE TO WORK FROM
HOME
    * WE STILL HAVE A NUMBER OF DEVELOPMENT OBJECTIVES TO
ACHIEVE IN
2020, PARTICULARLY OVERSEAS IN UNITED STATES, WHERE WE PLAN TO
STEP UP OUR OPERATIONS - CEO
    * THE COMPANY HAS REAL GROWTH POTENTIAL AND IN 2020 WE
EXPECT TO
FURTHER CONSOLIDATE OUR LEADERSHIP IN BIOTHERAPY MONITORING, IN
FRANCE AND IN OTHER PRIORITY MARKETS

Source text for Eikon:  ID:nBw4C5rGWa 
Further company coverage:  ALTHE.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))